Titre : Voies optiques

Voies optiques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Bahrain
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Voies optiques : Questions médicales les plus fréquentes", "headline": "Voies optiques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Voies optiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-11", "dateModified": "2025-05-06", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Voies optiques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Voies afférentes", "url": "https://questionsmedicales.fr/mesh/D000344", "about": { "@type": "MedicalCondition", "name": "Voies afférentes", "code": { "@type": "MedicalCode", "code": "D000344", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.612.220" } } }, "about": { "@type": "MedicalCondition", "name": "Voies optiques", "alternateName": "Visual Pathways", "code": { "@type": "MedicalCode", "code": "D014795", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Ariel Rokem", "url": "https://questionsmedicales.fr/author/Ariel%20Rokem", "affiliation": { "@type": "Organization", "name": "Department of Psychology, University of Washington, Seattle, Washington." } }, { "@type": "Person", "name": "N M Eliseeva", "url": "https://questionsmedicales.fr/author/N%20M%20Eliseeva", "affiliation": { "@type": "Organization", "name": "Burdenko Neurosurgical Center, Moscow, Russia." } }, { "@type": "Person", "name": "N K Serova", "url": "https://questionsmedicales.fr/author/N%20K%20Serova", "affiliation": { "@type": "Organization", "name": "Burdenko Neurosurgical Center, Moscow, Russia." } }, { "@type": "Person", "name": "Judith Ungewiss", "url": "https://questionsmedicales.fr/author/Judith%20Ungewiss", "affiliation": { "@type": "Organization", "name": "Fakultät für Optik und Mechatronik, Studiengang Augenoptik, Kompetenzzentrum \"Vision Research\", Hochschule Aalen, Anton-Huber-Str. 23, 73430, Aalen, Deutschland. Judith.Ungewiss@hs-aalen.de." } }, { "@type": "Person", "name": "Ivan Milenkovic", "url": "https://questionsmedicales.fr/author/Ivan%20Milenkovic", "affiliation": { "@type": "Organization", "name": "Fakultät für Medizin und Gesundheitswissenschaften, Carl von Ossietzky Universität Oldenburg, Oldenburg, Deutschland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based-multigene panel.", "datePublished": "2023-09-01", "url": "https://questionsmedicales.fr/article/37656691", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0291015" } }, { "@type": "ScholarlyArticle", "name": "Progress of the Gulf Cooperation Council (GCC) Countries Towards Achieving the 95-95-95 UNAIDS Targets: A Review.", "datePublished": "2023-04-20", "url": "https://questionsmedicales.fr/article/37079171", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s44197-023-00097-1" } }, { "@type": "ScholarlyArticle", "name": "Ecological study of breast cancer incidence among nationals and nonnationals in the Gulf Cooperation Council countries.", "datePublished": "2023-01-19", "url": "https://questionsmedicales.fr/article/36710613", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.26719/emhj.23.005" } }, { "@type": "ScholarlyArticle", "name": "Literature review of lupus nephritis From the Arabian Gulf region.", "datePublished": "2022-11-04", "url": "https://questionsmedicales.fr/article/36331103", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/09612033221137248" } }, { "@type": "ScholarlyArticle", "name": "Clinical carbapenem-resistant", "datePublished": "2022-10-11", "url": "https://questionsmedicales.fr/article/36304935", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fcimb.2022.1033305" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Système nerveux", "item": "https://questionsmedicales.fr/mesh/D009420" }, { "@type": "ListItem", "position": 3, "name": "Voies nerveuses", "item": "https://questionsmedicales.fr/mesh/D009434" }, { "@type": "ListItem", "position": 4, "name": "Voies afférentes", "item": "https://questionsmedicales.fr/mesh/D000344" }, { "@type": "ListItem", "position": 5, "name": "Voies optiques", "item": "https://questionsmedicales.fr/mesh/D014795" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Voies optiques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Voies optiques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Voies optiques", "description": "Comment diagnostiquer une lésion des voies optiques ?\nQuels tests sont utilisés pour évaluer la vision ?\nQuelles sont les causes possibles de troubles visuels ?\nComment évaluer la fonction des nerfs optiques ?\nQuel rôle joue l'IRM dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D014795?mesh_terms=Bahrain&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Voies optiques", "description": "Quels sont les symptômes d'une atteinte des voies optiques ?\nComment se manifeste une névrite optique ?\nQuels signes indiquent une compression des voies optiques ?\nQuels symptômes peuvent indiquer un AVC visuel ?\nComment reconnaître un glaucome ?", "url": "https://questionsmedicales.fr/mesh/D014795?mesh_terms=Bahrain&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Voies optiques", "description": "Comment prévenir les maladies des voies optiques ?\nQuels examens sont recommandés pour les personnes à risque ?\nComment réduire le risque de glaucome ?\nQuelles habitudes alimentaires favorisent la santé oculaire ?\nComment protéger ses yeux des blessures ?", "url": "https://questionsmedicales.fr/mesh/D014795?mesh_terms=Bahrain&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Voies optiques", "description": "Quels traitements existent pour la névrite optique ?\nComment traiter un glaucome ?\nQuelles sont les options pour les tumeurs des voies optiques ?\nComment gérer les troubles du champ visuel ?\nQuels médicaments sont utilisés pour traiter les AVC visuels ?", "url": "https://questionsmedicales.fr/mesh/D014795?mesh_terms=Bahrain&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Voies optiques", "description": "Quelles complications peuvent survenir après une névrite optique ?\nQuels risques sont associés à un AVC visuel ?\nComment le glaucome peut-il affecter la qualité de vie ?\nQuelles sont les conséquences d'une tumeur des voies optiques ?\nQuels effets secondaires peuvent résulter des traitements ?", "url": "https://questionsmedicales.fr/mesh/D014795?mesh_terms=Bahrain&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Voies optiques", "description": "Quels facteurs augmentent le risque de glaucome ?\nComment le tabagisme influence-t-il la santé oculaire ?\nQuels antécédents médicaux sont des facteurs de risque ?\nQuel rôle joue l'hypertension dans les maladies oculaires ?\nComment l'exposition au soleil affecte-t-elle les yeux ?", "url": "https://questionsmedicales.fr/mesh/D014795?mesh_terms=Bahrain&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une lésion des voies optiques ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un examen ophtalmologique complet et des imageries cérébrales comme l'IRM sont nécessaires." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la vision ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de vision, comme l'acuité visuelle et le champ visuel, sont couramment utilisés." } }, { "@type": "Question", "name": "Quelles sont les causes possibles de troubles visuels ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les causes incluent les tumeurs, les AVC, et les maladies dégénératives des nerfs optiques." } }, { "@type": "Question", "name": "Comment évaluer la fonction des nerfs optiques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme l'électrorétinogramme (ERG) et l'électroencéphalogramme (EEG) peuvent être utilisés." } }, { "@type": "Question", "name": "Quel rôle joue l'IRM dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM permet de visualiser les anomalies structurelles des voies optiques et du cerveau." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une atteinte des voies optiques ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent la perte de vision, des troubles du champ visuel et des douleurs oculaires." } }, { "@type": "Question", "name": "Comment se manifeste une névrite optique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par une vision floue, des douleurs à l'œil et une perte de couleur." } }, { "@type": "Question", "name": "Quels signes indiquent une compression des voies optiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes incluent une vision double, des maux de tête et une perte de vision progressive." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un AVC visuel ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes incluent une perte soudaine de vision d'un œil et des troubles de l'équilibre." } }, { "@type": "Question", "name": "Comment reconnaître un glaucome ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Le glaucome peut se manifester par une vision tunnel et des douleurs oculaires, surtout en cas aigu." } }, { "@type": "Question", "name": "Comment prévenir les maladies des voies optiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un contrôle régulier de la santé oculaire et un mode de vie sain sont essentiels." } }, { "@type": "Question", "name": "Quels examens sont recommandés pour les personnes à risque ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des examens ophtalmologiques réguliers sont recommandés, surtout pour les personnes âgées." } }, { "@type": "Question", "name": "Comment réduire le risque de glaucome ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une pression artérielle normale et éviter le tabagisme peut réduire le risque." } }, { "@type": "Question", "name": "Quelles habitudes alimentaires favorisent la santé oculaire ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en antioxydants, comme les légumes verts et les fruits, est bénéfique." } }, { "@type": "Question", "name": "Comment protéger ses yeux des blessures ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Porter des lunettes de protection lors d'activités à risque aide à prévenir les blessures oculaires." } }, { "@type": "Question", "name": "Quels traitements existent pour la névrite optique ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les corticostéroïdes sont souvent prescrits pour réduire l'inflammation et améliorer la vision." } }, { "@type": "Question", "name": "Comment traiter un glaucome ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le glaucome est traité par des médicaments, des laser ou une chirurgie pour réduire la pression intraoculaire." } }, { "@type": "Question", "name": "Quelles sont les options pour les tumeurs des voies optiques ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les options incluent la chirurgie, la radiothérapie et la chimiothérapie selon le type de tumeur." } }, { "@type": "Question", "name": "Comment gérer les troubles du champ visuel ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des rééducations visuelles et des aides visuelles peuvent aider à compenser les pertes." } }, { "@type": "Question", "name": "Quels médicaments sont utilisés pour traiter les AVC visuels ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des anticoagulants et des médicaments pour contrôler la pression artérielle sont souvent prescrits." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une névrite optique ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent une perte permanente de vision et des récidives de la maladie." } }, { "@type": "Question", "name": "Quels risques sont associés à un AVC visuel ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent des séquelles visuelles permanentes et des troubles cognitifs." } }, { "@type": "Question", "name": "Comment le glaucome peut-il affecter la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Le glaucome peut entraîner une perte de vision progressive, affectant les activités quotidiennes." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une tumeur des voies optiques ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les conséquences peuvent inclure des troubles visuels, des maux de tête et des troubles neurologiques." } }, { "@type": "Question", "name": "Quels effets secondaires peuvent résulter des traitements ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent entraîner des effets secondaires comme des infections, des douleurs et des nausées." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de glaucome ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge, les antécédents familiaux et certaines conditions médicales comme le diabète augmentent le risque." } }, { "@type": "Question", "name": "Comment le tabagisme influence-t-il la santé oculaire ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme est lié à un risque accru de maladies oculaires, y compris le glaucome et la cataracte." } }, { "@type": "Question", "name": "Quels antécédents médicaux sont des facteurs de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents de maladies auto-immunes ou de troubles neurologiques augmentent le risque." } }, { "@type": "Question", "name": "Quel rôle joue l'hypertension dans les maladies oculaires ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "L'hypertension peut endommager les vaisseaux sanguins de l'œil, augmentant le risque de glaucome." } }, { "@type": "Question", "name": "Comment l'exposition au soleil affecte-t-elle les yeux ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition excessive au soleil peut augmenter le risque de cataracte et de dégénérescence maculaire." } } ] } ] }

Sources (112 au total)

Progress of the Gulf Cooperation Council (GCC) Countries Towards Achieving the 95-95-95 UNAIDS Targets: A Review.

In 2014, the Joint United Nations Programme on HIV/AIDS (UNAIDS) and partners launched the 90-90-90 targets. These were further updated to correspond to 95-95-95 by the year 2025. We present an overvi... We extracted data from Global AIDS Monitoring (GAM), UNAIDS AIDS Info, HIV case reporting database, and the WHO global policy uptake for six countries: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and t... By the end of 2021, an estimated 42,015 people living with HIV (PLHIV) were residing in the GCC countries with prevalence levels below 0.01%. Data from four GCC countries, Bahrain, Oman, Qatar and UAE... The GCC countries have made great strides toward fulfilling the 95-95-95 targets, but the interim 2025 overall UNAIDS targets remain unmet. The GCC countries must strive diligently to accomplish the t...

Ecological study of breast cancer incidence among nationals and nonnationals in the Gulf Cooperation Council countries.

Breast cancer incidence is increasing in the Gulf Cooperation Council (GCC) countries: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates.... This study analysed geographical patterns, time trends, and age distribution of female breast cancer incidence among nationals and non-nationals in GCC countries.... Available cancer registry data for 1979-2016 were retrieved for the GCC countries. Age-standardized rates (ASRs) per 100 000 women were calculated using the World standard population. Comparisons were... From 1998 to 2012, incidence among nationals was highest in Bahrain (ASR 61.85), Kuwait (ASR 52.66), and Qatar (ASR 56.90) and lowest in Saudi Arabia (ASR 19.76), Oman (ASR 22.33), and United Arab Emi... Breast cancer incidence has increased over time among women in most GCC countries, likely reflecting the improvements in healthcare access and screening programmes. Nationals and non-nationals develop...

Literature review of lupus nephritis From the Arabian Gulf region.

The severity of lupus nephritis (LN) varies between different ethnicities. However, there are limited data regarding disease severity for LN in patients from the Arabian Gulf region; moreover, there a... A literature search using EMBASE was conducted in October, 2021 to identify publications reporting on the incidence, treatment practices, severity, pathophysiology or biomarkers associated with LN, fr... Of 3705 publications, 54 publications were identified as relevant. LN is one of the most commonly diagnosed renal diseases within the Arabian Gulf and approximately 10%-36% of all renal biopsies are f... This review identified that LN may manifest more severely among patients from the Arabian Gulf region than in other populations, such as Caucasian populations. A greater understanding of LN and the tr...

Comparison between the World Health Organization and Bahraini children growth standards.

The aim of this study was to investigate the growth patterns of Bahraini female and male infants/young children aged 0-24 months in the Kingdom of Bahrain.... A cross-sectional approach was employed to track the growth parameters among healthy Bahraini female and male infants/children aged 0-24 months. A multistage probability sampling criteria was used to ... Findings were compared with WHO Multicentre Growth Reference Study (MGRS) data. A total of 403 healthy infants/children (210 males and 193 females) were recruited. At birth, the mean weight, length, a... The outcomes of this study, presented as charts and tables, showed significant differences in comparison with the WHO-MGRS reference charts. Specifically, Bahraini children aged between 0 and 24 month...

Clinical Characteristics and Outcome of Infants with Biliary Atresia in Bahrain.

Though the prevalence of biliary atresia (BA) in the Middle East is low, its role in causing life-threatening liver diseases is disproportionately high. This study aimed to assess the prevalence, clin... A retrospective cohort review of cases of infants diagnosed with BA between January 1993 and December 2021 at Salmaniya Medical Complex, Bahrain, was conducted. Demographic, clinical, laboratory, imag... Out of 27 infants diagnosed with BA, 26 were included in the study. The overall prevalence was 0.007% and was significantly higher among Bahraini (0.006%) compared to the non-Bahraini population (0.00... BA is uncommon among infants in Bahrain. Despite effective treatment options, late diagnosis can lead to significant morbidity and mortality. Our study found a relatively low prevalence of NLS (53.8%)...

The estimated prevalence of osteoporosis in Bahrain: a multi-centered-based study.

the primary aim of this study was to examine the prevalence and risk factors of low bone mineral density in Bahrain.... this was a retrospective study, which targeted a cohort of 4822 Bahraini subjects (mean age 59.36 years: 93% females). Demographic data and results of lumbar and femur DEXA scan for the targeted sampl... The prevalence of low BMD was 62.3% (46.4% had osteopenia and 15.9% had osteoporosis). The highest rate of osteopenia was detected at the age group younger than 44 years. However, with increasing age,... We reported high prevalence of osteopenia and osteoporosis in Bahrain. Low BMD was more common in females, especially in postmenopausal women. Highest prevalence of osteopenia happened at young age. T...

A Narrative Review of the Coronavirus Disease 2019 Response in the Kingdom of Bahrain.

The Kingdom of Bahrain has reported more than 696,000 cases of coronavirus disease 2019 (COVID-19) and 1548 associated deaths as of December 26, 2022.... To better inform responses to future public health threats, this narrative review documents the challenges and responses to the COVID-19 pandemic in the Kingdom of Bahrain.... A PubMed search was conducted focusing on severe acute respiratory syndrome or COVID-19 in Bahrain. Additional relevant references were also included from the authors' personal reference collections.... The search indicated that Bahrain achieved well-established control of the pandemic through robust public health measures, including an early, comprehensive vaccination program. Bahrain was among the ... Early organization, robust and systematic protective measures, and a comprehensive vaccination program were key components of the Kingdom's response to the pandemic; traveler quarantines and attempts ...